Ex-ArthroCare Corporation (ARTC) Exec Pleads Guilty to $400 Million Stock Fraud Scheme
5/13/2013 9:03:21 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
David Applegate, the former senior vice president for ArthroCare's spinal business, pleads guilty to federal charges that he helped run a $400 million scheme to defraud investors. Ex-ArthroCare (NSDQ:ARTC) executive David Applegate pleaded guilty this week to federal charges that he helped run a scheme that eventually defrauded investors in the medical device company of some $400 million. Applegate, 54, pleaded to 1 count of conspiracy to commit securities, mail & wire fraud and another count of making false statements, for regulatory filings made with the SEC containing faked quarterly and annual sales figures. Applegate and another ex-ArthroCare exec, John Raffle, were arrested last summer and charged by the U.S. Justice Dept. with wire fraud and making false statements in connection with the alleged scheme to artificially inflate ArthroCare's share price by rigging its sales figures, according to court documents.
Help employers find you! Check out all the jobs and post your resume.